Array BioPharma Net Income Quarterly:
-21.59M for Dec. 31, 2012Array BioPharma Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -21.59M |
| Dec. 31, 2012 | -10.93M |
| Sept. 30, 2012 | -11.77M |
| June 30, 2012 | -8.027M |
| March 31, 2012 | -8.168M |
| Dec. 31, 2011 | -3.803M |
| Sept. 30, 2011 | -3.58M |
| June 30, 2011 | -21.75M |
| March 31, 2011 | -11.50M |
| Dec. 31, 2010 | -12.44M |
| Sept. 30, 2010 | -10.63M |
| June 30, 2010 | -15.85M |
| March 31, 2010 | -15.16M |
| Dec. 31, 2009 | -21.82M |
| Sept. 30, 2009 | -24.80M |
| June 30, 2009 | -26.70M |
| March 31, 2009 | -29.61M |
| Dec. 31, 2008 | -37.82M |
| Sept. 30, 2008 | -33.68M |
| June 30, 2008 | -32.44M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
ARRY Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Celldex Therapeutics | -17.33M |
| Cytokinetics | -12.62M |
| Ariad Pharmaceuticals | -64.67M |
ARRY Net Income Quarterly Rankings
| Overall |
34th percentile 5234 of 8002 |
| Sector |
11th percentile 604 of 684 in Healthcare |
| Industry |
17th percentile 205 of 248 in Biotechnology |
ARRY Net Income Quarterly Range, Past 5 Years
| Minimum | -37.82M | Dec 2008 |
| Maximum | -3.580M | Sep 2011 |
| Average | -18.10M |
